Insmed (INSM) Cash from Investing Activities (2010 - 2026)
Insmed (INSM) recorded Cash from Investing Activities of $24.51 million in Q2 2026, down 89.2% from $227.84 million a year earlier and down 90.8% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Cash from Investing Activities (2010 - 2026) Analysis & Trends
On a TTM basis, Insmed's Cash from Investing Activities came in at -$82.79 million as of Jun 30, 2026; for FY2025, it was -$64.58 million.
- Across earlier years, Cash from Investing Activities came in at -$583.18 million in FY2024, -$223.6 million in FY2023, -$34.58 million in FY2022 and -$64.29 million in FY2021.
- Quarterly Cash from Investing Activities has ranged from -$1 billion in Q3 2024 to $389.41 million in Q4 2025 over the past five years.
- On a year-over-year basis, Cash from Investing Activities rose in two of the last four quarters, with growth averaging 65.9%.
- Per Business Quant, the preceding three quarters came in at $265.52 million (Q1 2026), $389.41 million (Q4 2025) and -$762.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Insmed | 24.26 Bn | 18.76 Bn | 358.27 Mn | 24.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.51 Mn |
| Mar 31, 2026 | 265.52 Mn |
| Dec 31, 2025 | 389.41 Mn |
| Sep 30, 2025 | -762.23 Mn |
| Jun 30, 2025 | 227.84 Mn |
| Mar 31, 2025 | 80.41 Mn |
| Dec 31, 2024 | 131.76 Mn |
| Sep 30, 2024 | -1.00 Bn |
| Jun 30, 2024 | -6.78 Mn |
| Mar 31, 2024 | 295.32 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Jun 30, 2023 | -274.16 Mn |
| Mar 31, 2023 | 41.60 Mn |
| Dec 31, 2022 | 20.31 Mn |
| Sep 30, 2022 | 49.42 Mn |
| Jun 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | -101.41 Mn |
| Dec 31, 2021 | -51.22 Mn |
| Sep 30, 2021 | -8.40 Mn |
API Access
Insmed Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();